4G/5G promoter PAI-1 gene polymorphism is associated with plasmatic PAI-1 activity in Italians: A model of gene-environment interaction

被引：86

作者：

Burzotta, F

Di Castelnuovo, A

Amore, C

D'Orazio, A

Di Bitondo, R

Donati, MB

Iacoviello, L ^{[1
]}

机构：

[1] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Angela Valenti Lab Thrombosis Pharmacol, Dept Vasc Med & Pharmacol, I-66030 Santa Maria Imbaro, Italy

[2] TNO, IVVO, Gaubius Lab, NL-2300 AK Leiden, Netherlands

来源：

THROMBOSIS AND HAEMOSTASIS | 1998年 / 79卷 / 02期

关键词：

D O I：

10.1055/s-0037-1614991

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The PAI-1 gene promoter 4G/5G polymorphism was found to be associated with plasma PAI-1 activity in Northern and Central Europe populations, but no data are available on the association between this polymorphism and PAI-1 levels in Southern Europe countries (such as Italy) where the incidence of ischemic disorders is lower. This study shows that among populations with different incidence of atherothrombotic disorders the 4G/5G PAI-1 gene promoter polymorphism has the same importance in the regulation of plasma PAI-1 activity. Moreover, we have analysed some gene environmental interactions: the correlation between PAI-1 and cholesterol in non dyslipidemic subjects and the correlation between PAI-1 activity and tryglicerides in dyslipidemic subjects differed according to the 4G/5G genotype class. Thus, our findings suggest that, among subjects with or without metabolic disorders such as dyslipidemia, completely different gene-environment interactions may occur.

引用

页码：354 / 358

页数：5

共 27 条

[11] HAMSTEN A, 1987, LANCET, V2, P3
[12] INCREASED PLASMA-LEVELS OF A RAPID INHIBITOR OF TISSUE PLASMINOGEN-ACTIVATOR IN YOUNG SURVIVORS OF MYOCARDIAL-INFARCTION
HAMSTEN, A
WIMAN, B
DEFAIRE, U
BLOMBACK, M
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (25) : 1557 - 1563
[13] FIBRINOLYSIS AND ATHEROSCLEROSIS - AN UPDATE
HAMSTEN, A
ERIKSSON, P
[J]. FIBRINOLYSIS, 1994, 8 : 253 - 262
[14] JUHANVAGUE I, 1987, THROMB HAEMOSTASIS, V57, P67
[15] INVOLVEMENT OF THE HEMOSTATIC SYSTEM IN THE INSULIN-RESISTANCE SYNDROME - A STUDY OF 1500 PATIENTS WITH ANGINA-PECTORIS
JUHANVAGUE, I
THOMPSON, SG
JESPERSEN, J
[J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (12): : 1865 - 1873
[16] MANSFIELD MW, 1995, THROMB HAEMOSTASIS, V74, P842
[17] PLASMA TISSUE PLASMINOGEN-ACTIVATOR INHIBITOR LEVELS IN CORONARY-ARTERY DISEASE - CORRELATION WITH AGE AND SERUM TRIGLYCERIDE CONCENTRATIONS
MEHTA, J
MEHTA, P
LAWSON, D
SALDEEN, T
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (02) : 263 - 268
[18] HYPERTRIGLYCERIDEMIA AND REGULATION OF FIBRINOLYTIC-ACTIVITY
MUSSONI, L
MANNUCCI, L
SIRTORI, M
CAMERA, M
MADERNA, P
SIRONI, L
TREMOLI, E
[J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (01): : 19 - 27
[19] INSULIN SENSITIVITY IS NOT AN INDEPENDENT DETERMINANT OF PLASMA PLASMINOGEN-ACTIVATOR INHIBITOR-1 ACTIVITY
MYKKANEN, L
RONNEMAA, T
MARNIEMI, J
HAFFNER, SM
BERGMAN, R
LAAKSO, M
[J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (08): : 1264 - 1271
[20] NICOLOSO G, 1988, THROMB HAEMOSTASIS, V59, P299

← 1 2 3 →